Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study
- 1 February 2018
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 18 (2) , 188-197
Abstract
No abstract availableKeywords
Funding Information
- Gilead Sciences
This publication has 23 references indexed in Scilit:
- Significance and Clinical Management of Persistent Low-Level Viremia and Very-Low-Level Viremia in HIV-1-Infected PatientsAntimicrobial Agents and Chemotherapy, 2014
- HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failureAIDS, 2014
- Virologic Failure Following Persistent Low-level Viremia in a Cohort of HIV-Positive Patients: Results From 12 Years of ObservationClinical Infectious Diseases, 2013
- Prevalence and Significance of HIV-1 Drug Resistance Mutations among Patients on Antiretroviral Therapy with Detectable Low-Level ViremiaAntimicrobial Agents and Chemotherapy, 2012
- Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysisThe Lancet, 2012
- Structural barriers to ART adherence in Southern Africa: Challenges and potential ways forwardGlobal Public Health, 2011
- Antiretroviral Drug Resistance in HIV‐1‐Infected Patients with Low‐Level ViremiaThe Journal of Infectious Diseases, 2010
- Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic reviewThe Lancet Infectious Diseases, 2010
- Decreased Adherence to Antiretroviral Therapy Observed prior to Transient Human Immunodeficiency Virus Type 1 ViremiaThe Journal of Infectious Diseases, 2007
- Illustrating the Impact of a Time-Varying Covariate With an Extended Kaplan-Meier EstimatorThe American Statistician, 2005